Jun 30, 2026 08:02AM
Jun 30, 2026 08:00AM
Jun 10, 2026 08:02AM
Jun 10, 2026 08:00AM
May 7, 2026 07:00AM
May 4, 2026 08:04AM
May 4, 2026 08:00AM Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal
Apr 14, 2026 10:59AM
Apr 13, 2026 08:03AM
Apr 13, 2026 08:00AM
Apr 1, 2026 04:05PM
Apr 1, 2026 04:05PM
Mar 19, 2026 04:05PM
Feb 26, 2026 07:00AM Akebia Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial and Pipeline Highlights
Jan 12, 2026 08:02AM
Jan 12, 2026 08:00AM
Jan 6, 2026 08:01AM
Jan 6, 2026 08:00AM
Dec 1, 2025 07:00AM
Nov 10, 2025 07:00AM
Nov 6, 2025 06:30PM Vafseo® (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs
Oct 28, 2025 04:30PM
Oct 28, 2025 04:30PM
Oct 20, 2025 08:08AM
Aug 21, 2025 08:01AM
Aug 21, 2025 08:00AM
Aug 7, 2025 07:00AM
Aug 4, 2025 08:00AM Akebia Initiates Vafseo® (vadadustat) Post-Marketing Study in Conjunction with Large Dialysis Organization
Jun 4, 2025 08:01AM
Jun 4, 2025 08:00AM
May 8, 2025 07:00AM
Apr 3, 2025 08:01AM
Apr 3, 2025 08:00AM
Mar 13, 2025 07:00AM
Jan 13, 2025 08:06AM Akebia Therapeutics (AKBA) Announces Multiple Positive Business Updates
Jan 13, 2025 08:00AM
Dec 3, 2024 07:00AM
Nov 14, 2024 08:00AM
Nov 7, 2024 07:00AM
Oct 22, 2024 08:03AM
Oct 22, 2024 08:00AM
Oct 15, 2024 08:00AM Akebia Therapeutics Announces Seven Poster Presentations at ASN Kidney Week 2024
Oct 11, 2024 06:37AM
Oct 10, 2024 08:02AM
Oct 10, 2024 08:00AM
Oct 8, 2024 06:49AM
Oct 7, 2024 08:05AM
Oct 7, 2024 08:00AM
Sep 5, 2024 08:05AM Akebia Therapeutics (AKBA) and U.S. Renal Care Initiate the VOICE Trial of Vafseo (vadadustat) for Patients on Dialysis
Sep 5, 2024 08:00AM

325,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All